Drug recall · July 24, 2013
Oxytocin Injection recall
Why: Subpotent Drug; 15-month stability test station
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Oxytocin Injection, USP, (Synthetic), 10 USP Units/mL, for IV Infusion or IM Use, Rx Only, 1 mL vial, APP ) 10 USP Units/mL, 1 mL, APP Pharmaceuticals, LLC Schaumburg, IL, 60173, NDC 63323-012-01.
- Lots / codes
Lot #: 6003648, Exp. 6/2013
- Quantity
- 221,600 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- June 24, 2013 · Voluntary: Firm initiated
- Classified
- July 17, 2013
- Reported
- July 24, 2013
- Ended
- April 7, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Oxytocin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.